BioNTech SE - ADR vs Progressive Corp — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Progressive Corp trades at $211.51 (market cap $123.45B). The key difference: Progressive Corp is far larger — about 5.3× BioNTech SE - ADR's market cap, and Progressive Corp pays a 6.55% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | PGR | |
|---|---|---|
Market Cap | $23.31B | $123.45B |
Sector | Health | Financials |
52-Week High | $119.34 | $252.68 |
52-Week Low | $83.89 | $190.40 |
Enterprise Value | $6.60B | $131.66B |
Dividend Yield | — | 6.55% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →